Advanced Biomed Inc. (ADVB) vs Precipio, Inc. (PRPO)

Advanced Biomed Inc. and Precipio, Inc. are both Diagnostics & Research companies. Precipio, Inc. is the larger, with a market value of $40.4M against $8.1M — 5.0× the size. Precipio, Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 0.8×. Advanced Biomed Inc. has the higher net margin (0.00% vs −4.47%) and the lower return on invested capital (−33.4% vs −7.63%). Across the 13 metrics below, Advanced Biomed Inc. leads on 9 and Precipio, Inc. on 4.

Valuation

Metric ADVB PRPO Diagnostics & Research median
P/E 0.77 n/m 35.56
P/S n/m 1.41 4.37
P/B 0.41 2.59 3.06
Price to free cash flow n/m 48.43 35.76
EV/EBITDA n/m 122.01 24.35
EV/Sales n/m 1.33 5.51
Earnings yield 129.37% (2.99%) (1.89%)
Free cash flow yield (90.81%) 2.06% (0.15%)

Profitability

Metric ADVB PRPO Diagnostics & Research median
Gross margin — 44.11% 50.89%
Operating margin 0.00% (5.68%) (8.57%)
Net margin 0.00% (4.47%) (6.37%)
Free cash flow margin 0.00% 2.90% 0.00%
Return on equity 84.77% (8.98%) (2.92%)
Return on assets 36.47% (6.05%) (6.71%)
Return on invested capital (33.43%) (7.63%) 0.00%

Growth

Metric ADVB PRPO Diagnostics & Research median
Revenue growth (TTM) — 28.04% 7.69%
EPS growth (last fiscal year) 266.53% 92.15% 25.92%
Revenue growth, 5-year CAGR — 31.60% 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB PRPO Diagnostics & Research median
Debt to equity 0.00 0.07 0.11
Current ratio 9.33 1.77 2.02
Net debt to EBITDA 0.06 (3.30) 0.70

Dividend

Metric ADVB PRPO Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric ADVB PRPO Diagnostics & Research median
Market cap 8.06m 40.35m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack